Literature DB >> 2506129

Inactivation of botulinum and tetanus toxins by chelators.

S D Bhattacharyya1, H Sugiyama.   

Abstract

Purified type A botulinum toxin of about 10(6) mouse 50% lethal doses per ml was greater than 99.9% inactivated when incubated at pH 7.4 for 30 min at 37 degrees C in 20 mM 1,10-phenanthroline (PTL) or 2,2'-dipyridyl (DPD) and was 96% inactivated when incubated in 70 mM 8-hydroxyquinoline-5-sulfonic acid (HQL), but was not affected when incubated in 200 mM EDTA. When used as a representative of the chelating agents, PTL inactivated greater than or equal to 99.9% of toxicity in the culture filtrate of C. botulinum type A, B, and E strains. Highly purified tetanus toxin at 2.5 x 10(5) 50% lethal doses per ml lost all toxicity in 40 mM PTL or 150 mM DPD but was not detectably affected by 100 mM HQL (the highest concentration possible). Toxin inactivation by 20 mM PTL was completely blocked when the PTL was prereacted with an equimolar amount of Zn2+ and significantly reduced when it was preincubated with one-third its molar amount of Fe2+. DPD at 20 mM had little toxin-inactivating potency when preincubated with an equimolar amount of Zn2+ and only some of this potency when preincubated with an equimolar amount of Fe2+. Toxicity was not recovered by adding Zn2+ or Fe2+ to PTL-treated toxin. Neutron activation analysis of type A toxin showed that for each toxin molecule present, there was 1 atom of Fe, 0.4 atom of Zn, and 22 to 55 atoms each of Ca and Mg. The biological activity of botulinum toxin seems to depend on a metal component, which is likely to be Fe.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506129      PMCID: PMC260769          DOI: 10.1128/iai.57.10.3053-3057.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  The mechanism of inhibition of carboxypeptidase A by 1,10-phenanthroline.

Authors:  J P FELBER; T L COOMBS; B L VALLEE
Journal:  Biochemistry       Date:  1962-03       Impact factor: 3.162

2.  Molecular construction of Clostridium botulinum type F progenitor toxin.

Authors:  I Ohishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1975-04

3.  Disulfide-toxicity relationship of botulinal toxin types A, E, and F.

Authors:  H Sugiyama; R Das Gupta; K H Yang
Journal:  Proc Soc Exp Biol Med       Date:  1973-07

4.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

5.  Studies on phosphomannose isomerase. II. Characterization as a zinc metalloenzyme.

Authors:  R W Gracy; E A Noltmann
Journal:  J Biol Chem       Date:  1968-08-10       Impact factor: 5.157

6.  Significance of 12S toxin of Clostridium botulinum type E.

Authors:  M Kitamura; S Sakaguchi; G Sakaguchi
Journal:  J Bacteriol       Date:  1969-06       Impact factor: 3.490

7.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

Review 8.  Molecular pharmacology of botulinum toxin and tetanus toxin.

Authors:  L L Simpson
Journal:  Annu Rev Pharmacol Toxicol       Date:  1986       Impact factor: 13.820

Review 9.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

10.  Evidence that subunits of type A botulinum toxin need not be linked by disulfide.

Authors:  S D Bhattacharyya; H Sugiyama; P Rust; D Lacey
Journal:  Toxicon       Date:  1988       Impact factor: 3.033

View more
  5 in total

1.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

2.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

Review 3.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

4.  Protein kinase C and clostridial neurotoxins affect discrete and related steps in the secretory pathway.

Authors:  M A Bittner; R W Holz
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

5.  Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments.

Authors:  J A Giménez; B R DasGupta
Journal:  J Protein Chem       Date:  1992-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.